Summary:
- Iambic, a startup, has raised $100 million to conduct clinical trials for cancer drugs discovered using artificial intelligence (AI) technology.
- The company's AI platform analyzes vast amounts of data to identify promising drug candidates that could be effective in treating various types of cancer.
- By leveraging AI, Iambic aims to accelerate the drug discovery process and bring new cancer treatments to patients more quickly than traditional methods.